“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”
Category: SCIENCE
Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects
Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain
The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine.
Study: Adult-Use Cannabis Access Associated with Decreased Sales of OTC Sleep Aids
Researchers reported: “For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.”
Study Finds “Little Support” for Cannabis Impacting Cognitive Abilities
The occasional use of cannabis during late adolescence is not independently associated with adverse effects on cognitive abilities in young adulthood, according to longitudinal data published in the journal Drug and Alcohol Dependence. A team of investigators affiliated with the University of Colorado at Boulder assessed the impact of cannabis use on cognition, executive function, and working memory in 856 individual twins. Cannabis consumers were compared to their non-using twins in late adolescence and then again in their early twenties. Most of the cannabis consuming participants in the study reported occasional use of the substance, but not daily use. Authors found “little support for a causal effect of cannabis use on cognition. This conclusion is consistent with those from previous…
Study: Daily Cannabis Use Among Pain Patients Associated with Less Non-Prescription Opioid Use
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”
Report: Potency of CBD Products Sold Online Often Deviates From What Is Advertised
CBD-infused products sold online frequently possess significantly lower percentages of CBD than advertised, according to a report published by the online watchdog group LegitScript.com. Investigators lab-tested 30 CBD products obtained from leading online retailers. Twenty of the thirty products possessed significant deviations in CBD content as compared to what was advertised. Sixteen of the 20 products contained lower percentages of CBD than the amount stated on the product’s label — a finding that is consistent with prior analyses. Some of the products also tested positive for the presence of solvent residue and elevated levels of heavy metals – findings that are also consistent with those of other studies. Authors also evaluated the marketing practices of 300 leading online CBD retailers….
Study: Pain Patients Report Significant Health Improvements Following Enactment of Medical Cannabis Access Laws
“Individuals who report having pain limiting that limits their daily activity see large health improvements. This is the strongest evidence that a group with a high probability of pain medication use sees large benefits from medical marijuana laws.”
Senate Caucus to Hold Hearing This Wednesday on Marijuana and Public Health
On Wednesday, October 23rd, members of the Senate Senate International Narcotics Control Caucus (aka the Drug Caucus) will hold a hearing entitled “Marijuana and America’s Health: Questions and Issues for Policy Makers.”
Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis.